|
Kisquali low platelets
|
|
0
|
5
|
2 November 2026
|
|
Fulvestrant and Capiversatib
|
|
0
|
24
|
31 October 2026
|
|
Enhertu Finally Approved!
|
|
4
|
222
|
31 October 2026
|
|
Starting on fulvestrant and capcetabine
|
|
4
|
132
|
26 October 2026
|
|
Capivasertib and faslodex?
|
|
11
|
308
|
21 October 2026
|
|
Inflammatory Brest cancer
|
|
10
|
364
|
15 October 2026
|
|
Liver Mets Ablasion
|
|
1
|
101
|
14 October 2026
|
|
Succesful on Capecitabine
|
|
43
|
9005
|
9 October 2026
|
|
Elacestrant (Orserdu)
|
|
12
|
1947
|
30 September 2026
|
|
The cancer team don’t seem to have a plan
|
|
6
|
397
|
27 September 2026
|
|
Ulcerating cancer
|
|
1
|
171
|
26 September 2026
|
|
Brain met, surgery, SRS now Docetaxel & Phesgo
|
|
17
|
1412
|
20 September 2026
|
|
Changes on non refridgerated Ribo
|
|
0
|
89
|
10 September 2026
|
|
Reaction to Ribociclib
|
|
5
|
225
|
4 September 2026
|
|
Help us shape our submission to NICE
|
|
0
|
106
|
4 September 2026
|
|
Anyone on Enhertu?
|
|
6
|
6556
|
24 August 2026
|
|
Sign the Petition & Help Extend Lives: Enhertu Now
|
|
9
|
279
|
21 August 2026
|
|
Everolimus+Exemestane
|
|
2
|
455
|
18 August 2026
|
|
Mirtazapine anyone?
|
|
5
|
194
|
30 July 2026
|
|
Weekly Paclitaxel Secondaries
|
|
5
|
270
|
25 July 2026
|
|
Pause in Capivasertib due to rash side effect
|
|
2
|
104
|
17 July 2026
|
|
Tamoxifen for metastatic breast cancer
|
|
9
|
1365
|
14 July 2026
|
|
Support needed
|
|
3
|
418
|
10 June 2026
|
|
Capecitabine when to take
|
|
3
|
355
|
7 June 2026
|
|
Lobular Breast Cancer
|
|
17
|
5318
|
6 June 2026
|
|
BROC - has anyone tried this supplement?
|
|
8
|
2070
|
31 May 2026
|
|
Calivasertib side effects
|
|
4
|
175
|
13 May 2026
|
|
We’re looking for people to help shape our response to the Scottish Medicines Consortium’s (SMC) appraisal of elacestrant (korserdu) for treating ER positive, HER-2 negative secondary breast cancer with an ESR1 mutation
|
|
1
|
192
|
11 May 2026
|
|
Sore lump in groin
|
|
1
|
160
|
28 April 2026
|
|
Surgery for Secondary
|
|
5
|
603
|
23 April 2026
|